Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
Today we have again brought GMAT Ninja live to discuss a burning issue - how to study for the competition exams such as GMAT or CAT while working full time. We all are busy working professionals;
We explore the incredible MBA journey of Randeep Singh, a US military veteran, who successfully transitioned from the military to an MBA at Stanford GSB, Chicago Booth, and Berkeley Haas.
Use code ACTION20 at checkout. Act fast! This discount ends April 15, 2024. Valid on Complete Course, Advanced Course, On Demand Course, Bootcamp Course, Tutoring, and Executive Assessment Course.
András Domschitz recently scored 735 (99.5%) on the GMAT Focus Edition. In this video, we discuss his GMAT Focus study plan and techniques and how TTP’s self-study course helped him achieve an incredible 735 score on the GMAT Edition.
In this webinar, Rajat Sadana, GMAT Club’s #1 rated expert will help you create a personalized study plan so that each one of you can visualize your journey to a top GMAT Focus Score.
After just 3 months of studying with the TTP GMAT Focus course, Conner scored an incredible 755 (Q89/V90/DI83) on the GMAT Focus. In this live interview, he shares how he achieved his outstanding 755 (100%) GMAT Focus score on test day.
A manufacturer of anti-inflammatory medicine for infants
[#permalink]
05 Dec 2004, 05:28
Show timer
00:00
A
B
C
D
E
Difficulty:
(N/A)
Question Stats:
0%
(00:00)
correct
0%
(00:00)
wrong
based on 0
sessions
HideShow
timer Statistics
A manufacturer of anti-inflammatory medicine for infants recently discovered that a batch of its medicine still in production contained improper and potentially harmful quantities of certain compounds. The manufacturer immediately issued a recall of all recently shipped batches, but some executives went on to propose that all remaining batches be destroyed as well, even though it would cost the company millions of dollars in lost revenue.
The proposal to destroy the remaining batches of medicine depends on which of the following assumptions?
A. The company will be able to recoup any lost revenue through sales of other medicines.
B. It cannot feasibly be determined whether the remaining batches of medicine are salable.
C. The public will not be aware of the destruction of the remaining medicine.
D. Destruction of the remaining batches would ensure that improper quantities of the compound are not present in any of the company's products.
E. Some of the remaining batches of medicine do not contain harmful quantities of the compound in question.
Archived Topic
Hi there,
This topic has been closed and archived due to inactivity or violation of community quality standards. No more replies are possible here.
Still interested in this question? Check out the "Best Topics" block below for a better discussion on this exact question, as well as several more related questions.
Re: A manufacturer of anti-inflammatory medicine for infants
[#permalink]
06 Dec 2004, 11:02
gayathri wrote:
Can someone explain why it is B?
gayathri,
Let me try, the proposal to destroy all the other batches would insure that there is no chance that any other children would get affected by this faulty medicine, that is what the proposal is trying to acheive. To acheive this goal the manufacturer is assuming that there is no other way to test them, if this not true then they could test the rest of the batches and didn't have to go by the proposal. I hope it makes some sense.
Re: A manufacturer of anti-inflammatory medicine for infants
[#permalink]
06 Dec 2004, 11:55
A. The company will be able to recoup any lost revenue through sales of other medicines.
Company is not worried about sales nor revenues , eliminate A
B. It cannot feasibly be determined whether the remaining batches of medicine are salable.
If company can determine which batch has faulty medicine it can destroy only that batch but since company cannot pinpoint the problematic batch and it doesn't know which batch can be sold .
B is a proper answer for this
C. The public will not be aware of the destruction of the remaining medicine. - out of scope
D. Destruction of the remaining batches would ensure that improper quantities of the compound are not present in any of the company's products.
- some of the batches might be good in this so there is no need to destroy all of them . E. Some of the remaining batches of medicine do not contain harmful quantities of the compound in question. - out of scope
Archived Topic
Hi there,
This topic has been closed and archived due to inactivity or violation of community quality standards. No more replies are possible here.
Still interested in this question? Check out the "Best Topics" block above for a better discussion on this exact question, as well as several more related questions.
Thank you for understanding, and happy exploring!
gmatclubot
Re: A manufacturer of anti-inflammatory medicine for infants [#permalink]